| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
RPS3 |
RPS3, OK/SW-cl.26: 40S ribosomal protein S3 |
11.750 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
STAG2 |
STAG2, SA2: Cohesin subunit SA-2 |
11.750 |
Evidence |
|
| APEX1 |
APEX1, APE, APEX, APX, HAP1, REF1: DNA-(apurinic or apyrimidinic site) lyase |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
11.750 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
ORC1L |
ORC1L, ORC1, PARC1: Origin recognition complex subunit 1 |
11.750 |
Evidence |
|
| DDX5 |
DDX5, G17P1, HELR, HLR1: Probable ATP-dependent RNA helicase DDX5 |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
11.750 |
Evidence |
|
| LAMR1 |
RPSA, LAMBR, LAMR1: 40S ribosomal protein SA |
STK24 |
STK24, MST3, STK3: Serine/threonine-protein kinase 24 |
11.750 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
NUP153 |
IPI00514528 |
11.750 |
Evidence |
|
| TF |
TF, PRO1400: Serotransferrin precursor |
IGFALS |
IGFALS, ALS: Insulin-like growth factor-binding protein complex acid labile chai |
11.750 |
Evidence |
|
| TTR |
TTR, PALB: Transthyretin precursor |
PON1 |
IPI00555746 |
11.750 |
Evidence |
|
| PPP1R12A |
PPP1R12A, MBS, MYPT1: Protein phosphatase 1 regulatory subunit 12A |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
11.750 |
Evidence |
|
| CHEK1 |
CHEK1, CHK1: Serine/threonine-protein kinase Chk1 |
CDK2 |
CDK2: Cell division protein kinase 2 |
11.750 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
PTPRJ |
PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor |
11.750 |
Evidence |
|
| MPL |
MPL, TPOR: Thrombopoietin receptor precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
11.750 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
CEBPA |
CEBPA: CCAAT/enhancer-binding protein alpha |
11.750 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
CEBPA |
CEBPA: CCAAT/enhancer-binding protein alpha |
11.750 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
CEBPA |
CEBPA: CCAAT/enhancer-binding protein alpha |
11.750 |
Evidence |
|
| TGFB1 |
TGFB1, TGFB: Transforming growth factor beta-1 precursor |
DAPK2 |
DAPK2: Death-associated protein kinase 2 |
11.750 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
FRAP1 |
FRAP1, FRAP, FRAP2: FKBP12-rapamycin complex-associated protein |
11.750 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
11.750 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
IGFBP7 |
IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor |
11.750 |
Evidence |
|
| DSC3 |
DSC3, DSC4: Desmocollin-3 precursor |
APC2 |
APC2, APCL: Adenomatous polyposis coli protein 2 |
11.730 |
Evidence |
|
| DSC2 |
DSC2, DSC3: Desmocollin-2 precursor |
APC2 |
APC2, APCL: Adenomatous polyposis coli protein 2 |
11.730 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
AMHR2 |
AMHR2, AMHR: Anti-Muellerian hormone type-2 receptor precursor |
11.730 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
TYRO3 |
TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor |
11.730 |
Evidence |
|
| CDH5 |
CDH5: Cadherin-5 precursor |
APC2 |
APC2, APCL: Adenomatous polyposis coli protein 2 |
11.730 |
Evidence |
|